Skip to main content
CBRS
NASDAQ Technology

Culper Short Report Claims Cerebras Chips Fail in 18-30 Months, Flags Accounting and OpenAI Deal Risk

Tom Rudovsky · Reported by Benzinga
More coverage: Semiconductor Stocks · Technology
Sentiment info
Negative
Importance info
8
Price
$107.74
Mkt Cap
$24.117B
52W Low
$106.13
52W High
$386.34
52W Position info
1.5% above low
Off High info
72% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

CBRS is trading near its 52-week low of $106.13 (1.5% above the low).

Summary

Culper Research published a short report Wednesday claiming Cerebras' wafer-scale processors break down after 18 to 30 months in service, arguing the lifespan undermines the business model. The firm says the thermal-expansion fix CEO Andrew Feldman described as invented in-house is actually PariPoser, a material developed at Bell Labs in the 1980s, and alleges Cerebras runs filler computations to keep wafers from cooling. Culper also attacks the accounting: it says the April 2026 S-1 stretched the assumed useful life of its computers to 3 to 5 years from 1.5 to 3 years without explanation, and recalculates first-half gross margin at 24.0% versus the 29.9% reported using a 2.25-year life. On the December 2025 OpenAI agreement, Culper estimates OpenAI pays 20% to 77% less than hardware buyers, putting the contract's value anywhere from roughly even to a negative net present value of $13.8 billion. Share supply adds pressure: 19.4 million shares became eligible for sale Wednesday, more than 50 million more become tradable in early November, and insiders have cashed out over $400 million since the IPO. Shares were down 5.20% at $113.11, near the 52-week low of $106.13. Note that some evidence comes from unnamed ex-staff and customers and Culper labels its conclusions opinions; Cerebras did not immediately respond to a request for comment.

At the time of this announcement, CBRS was trading at $107.74 on NASDAQ in the Technology sector, with a market capitalization of approximately $24.1B. The 52-week trading range was $106.13 to $386.34. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

CBRS - Latest Insights

CBRS
Oct 28, 2026, 12:03 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $114.96
Real-time Price: $107.44 info
Change: -$7.52 (-7%) info
Market Cap: $24.05B info
CBRS
Oct 12, 2026, 12:52 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $147.16
Real-time Price: $107.44 info
Change: -$39.72 (-27%) info
Market Cap: $24.05B info
CBRS
Oct 12, 2026, 8:56 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $152.89
Real-time Price: $107.44 info
Change: -$45.45 (-30%) info
Market Cap: $24.05B info
CBRS
Oct 02, 2026, 6:23 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $170.01
Real-time Price: $107.44 info
Change: -$62.57 (-37%) info
Market Cap: $24.05B info
CBRS
Sep 30, 2026, 10:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $184.80
Real-time Price: $107.44 info
Change: -$77.36 (-42%) info
Market Cap: $24.05B info